About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT05852470

Evaluation of Clareon Vivity/Vivity Toric

This study seeks to generate clinical data from subjects previously implanted with the Clareon Vivity/Vivity Toric Intraocular Lenses (IOLs) or Clareon Monofocal/Clareon Toric IOLs. This study will as...

Lead sponsor: Alcon Research•7 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Alcon Research

Both eyes of a subject must qualify for enrollment into this study. A total of 2 scheduled visits are planned. The visits include a Screening visit (Visit 0) and a visit after screening (Visit 1). The subject must be 90-180 days post second eye implant at the time of Visit 1. Visit 1 should occur 1 to 14 days after Visit 0. Subject participation is expected to last approximately 2 weeks.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Understand and sign an approved Informed Consent form
•Previously implanted in both eyes with Clareon Vivity/Clareon Vivity Toric or Clareon Monofocal/Clareon Toric IOLs for at least 3 months and up to 6 months (90 to 180 days) after second eye implant.

Exclusion Criteria

•History of clinically significant ocular co-morbidities that would affect surgical outcomes based on investigator expert medical opinion.
•Subjects who were targeted to monovision defined as ≥ 1.50 Diopter (D) of anisometropia.
•Clinically significant PCO (posterior capsule opacification) affecting vision.

Related studies

Feasibility Study of an Accommodating IOL Design

NCT07147192 · Aphakia

Long-term Results of Two Surgical Methods for Scleral IOL Implantation and Fixation in Eyes Without Capsular Support: Yamane- Versus 4-flanged Technique

NCT06102109 · Lens Luxation, IOL Subluxation, and more

Active Not RecruitingNA

Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix

NCT05796453 · Aphakia, Astigmatism, and more

Investigation of the Safety and Effectiveness of Monofocal Toric Intraocular Lens (IOL)

NCT06399211 · Eye Diseases, Postcataract Aphakia, and more

Not Yet RecruitingNA

Contralateral Claims Study of Clareon Vivity Pro

NCT07484191 · Aphakia, Presbyopia

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 24, 2026Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment155

Start dateMay 2023

Last updatedFeb 24, 2026

Condition

Locations shown

Wolstan Goldberg Eye Associates

Torrance, California

Eye Center of Northern Colorado, PC

Fort Collins, Colorado

Grosinger, Spigelman & Grey Eye Surgeons, P.C.

Bloomfield Hills, Michigan

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 24, 2026Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions